Antifungal compounds from cyanobacteria

Marine Drugs

Volumn 13, Issue 4, 2015, Pages 2124-2140

  Shishido, Tânia K ^a   Humisto, Anu ^a   Jokela, Jouni ^a   Liu, Liwei ^a   Wahlsten, Matti ^a   Tamrakar, Anisha ^a   Fewer, David P ^a   Permi, Perttu ^a   Andreote, Ana P D ^b   Fiore, Marli F ^b   Sivonen, Kaarina ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

16S rRNA; Aspergillus sp; Candida albicans; Drug leads; Natural products

Indexed keywords

ANTIFUNGAL AGENT; HASSALLIDIN; SCYTOPHYCIN; UNCLASSIFIED DRUG; CYCLOPEPTIDE; FRESH WATER; GLYCOLIPID; LIPOPEPTIDE; PYRAN DERIVATIVE; SALT WATER;

ANABAENA; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; BACTERIAL STRAIN; BACTERIUM ISOLATION; BRAZIL; CANDIDA ALBICANS; CYANOBACTERIUM; CZECH REPUBLIC; DISK DIFFUSION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG SCREENING; FINLAND; FISCHERELLA; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; NOSTOC; NOSTOCALES; SCYTONEMA; STIGONEMATALES; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; DRUG DEVELOPMENT; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR TYPING; PHYLOGENY; SPECIES DIFFERENCE;

ANABAENA; ANABAENA CYLINDRICA; ANABAENA SP.; ASPERGILLUS; CANDIDA ALBICANS; CYANOBACTERIA; FISCHERELLA SP.; NOSTOC; NOSTOC SP.; NOSTOCALES; PROKARYOTA; SCYTONEMA HOFMANNI; SCYTONEMA SP.; STIGONEMATALES;

ANABAENA; ANTIFUNGAL AGENTS; ASPERGILLUS FLAVUS; BRAZIL; CANDIDA ALBICANS; CYANOBACTERIA; CZECH REPUBLIC; DRUG DISCOVERY; FINLAND; FRESH WATER; GLYCOLIPIDS; LIPOPEPTIDES; MOLECULAR STRUCTURE; MOLECULAR TYPING; NOSTOC; PEPTIDES, CYCLIC; PHYLOGENY; PYRANS; SALINE WATERS; SPECIES SPECIFICITY;

EID: 84928472854     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md13042124     Document Type: Article

References (32)

1. Whitton, B.A.; Potts, M. Introduction to cyanobacteria. In The Ecology of Cyanobacteria. Their Diversity in Time and Space; Whitton, B.A., Potts, M., Eds.; Kluwer Academic: Dodrecht, The Netherlands, 2000; pp. 61-120.
2. Kaasalainen, U.; Fewer, D.P.; Jokela, J.; Wahlsten, M.; Sivonen, K.; Rikkinen, J. Cyanobacteria produce a high variety of hepatotoxic peptides in lichen symbiosis. Proc. Natl. Acad. Sci. USA. 2012, 109, 5886-5891.
3. Sønstebø, J.H.; Rohrlack, T. Possible implications of chytrid parasitism for population subdivision in freshwater cyanobacteria of the genus Planktothrix. Appl. Environ. Microbiol. 2011, 77, 1344-1351.
4. Rohrlack, T.; Christiansen, G.; Kurmayer, R. Putative antiparasite defensive system involving ribosomal and nonribosomal oligopeptides in cyanobacteria of the genus Planktothrix. Appl. Environ. Microbiol. 2013, 79, 2642-2647.
5. Kajiyama, S.; Kanzaki, H.; Kawazu, K.; Kobayashi, A. Nostofungicidine, an antifungal lipopeptide from the field-grown terrestrial blue-green alga Nostoc commune. Tetrahedron Lett. 1998, 39, 3737-3740.
6. Burja, A.M.; Banaigs, B.; Abou-Mansour, E.; Burgess, J.G.; Wright, P.C. Marine cyanobacteria - A prolific source of natural products. Tetrahedron 2001, 57, 9347-9377.
7. Abed, R.M.; Dobretsov, S.; Sudesh, K. Applications of cyanobacteria in biotechnology. J. Appl. Microbiol. 2009, 106, 1-12.
8. Cane, D.E.; Walsh, C.T.; Khosla, C. Harnessing the biosynthetic code: Combinations, permutations, and mutations. Science 1998, 282, 63.
9. Cane, D.E.; Walsh, C.T. The parallel and convergent universes of polyketide synthases and nonribosomal peptide synthetases. Chem. Biol. 1999, 6, R319-R325.
10. Vestola, J.; Shishido, T.K.; Jokela, J.; Fewer, D.P.; Aitio, O.; Permi, P.; Wahlsten, M.; Wang, H.; Rouhiainen, L.; Sivonen, K. Hassallidins, antifungal glycolipopeptides, are widespread among cyanobacteria and are the end-product of a nonribosomal pathway. Proc. Natl. Acad. Sci. USA 2014, 111, E1909-E1917.
11. Loeffler, J.; Stevens, D.A. Antifungal drug resistance. Clin. Infect. Dis. 2003, 36, S31-S41.
12. Khan, M.S.A.; Ahmad, I.; Aqil, F.; Owais, M.; Shahid, M.; Musarrat, J. Virulence and pathogenicity of fungal pathogens with special reference to Candida albicans. In Combating Fungal Infections; Ahmad, I., Owais, M., Shahid, M., Aqil, F., Eds.; Springer-Verlag: Berlin, Germany, 2010; pp. 21-45.
13. World Health Organization. Antifungal drug resistance: The example of invasive Candidiasis. In Antimicrobial Resistance: Global Report on Surveillance; WHO Press: Geneva, Switzerland, 2014; pp. 62-65.
14. Gugger, M.; Lyra, C.; Henriksen, P.; Couté, A.; Humbert, J.F.; Sivonen, K. Phylogenetic comparison of the cyanobacterial genera Anabaena and Aphanizomenon. Int. J. Syst. Evol. Microbiol. 2002, 52, 1867-1880.
15. Shishido, T.K.; Kaasalainen, U.; Fewer, D.P.; Rouhiainen, L.; Jokela, J.; Wahlsten, M.; Fiore, M.F.; Yunes, J.S.; Rikkinen, J.; Sivonen, K. Convergent evolution of [D-Leucine(1)] microcystin-LR in taxonomically disparate cyanobacteria. BMC Evol. Biol. 2013, 13, 86.
16. Ishibashi, M.; Moore, R.E.; Patterson, G.M.L. Scytophycins, Cytotoxic and antimycotic agents from the cyanophyte Scytonema pseudohofmanni. J. Org. Chem. 1986, 51, 5300-5306.
17. Carmeli, S.; Moore, R.E.; Patterson, G.M.L. Tolytoxin and new scytophycins from three species of Scytonema. J. Nat. Prod. 1990, 53, 1533-1542.
18. Jung, J.H.; Moore, R.E.; Patterson, G.M.L. Scytophycins from a blue-green alga belonging to the nostocaceae. Phytochemistry 1991, 30, 3615-3616.
19. Tomsickova, J.; Ondrej, M.; Cerny, J.; Hrouzek, P.; Kopecky, J. Analysis and detection of scytophycin variants by HPLC-ESI-MS. Chem. Nat. Compd. 2014, 49, 1170-1171.
20. Kubanek, J.; Jensen, P.R.; Keifer, P.A.; Sullards, M.C.; Collins, D.O.; Fenical, W. Seaweed resistance to microbial attack: A targeted chemical defense against marine fungi. Proc. Natl. Acad. Sci. USA 2003, 100, 6916-6921.
21. Yeung, K.-S.; Paterson, I. Actin-binding marine macrolides: Total synthesis and biological importance. Angew. Chem. Int. 2002, 41, 4632-4653.
22. Patterson, G.M.L.; Bolis, C.M. Fungal cell wall polysaccharides elicit an antifungal secondary metabolite (phytoalexin) in the cyanobacterium Scytonema ocelutum. J. Phycol. 1997, 33, 54-60.
23. Neuhof, T.; Schmieder, P.; Preussel, K.; Dieckmann, R.; Pham, H.; Bartl, F.; von Döhren, H. Hassallidin A, a glycosylated lipopeptide with antifungal activity from the cyanobacterium Hassallia sp. J. Nat. Prod. 2005, 68, 695-700.
24. Neuhof, T.; Schmieder, P.; Seibold, M.; Preussel, K.; von Döhren, H. Hassallidin B-Second antifungal member of the Hassallidin family. Bioorg. Med. Chem. Lett. 2006, 16, 4220-4222.
25. Bui, T.H.; Wray, V.; Nimtz, M.; Fossen, T.; Preisitsch, M.; Schröder, G.; Wende, K.; Heiden, S.E.; Mundt, S. Balticidins A-D, antifungal hassallidin-like lipopeptides from the Baltic Sea cyanobacterium Anabaena cylindrica Bio33. J. Nat. Prod. 2014, 77, 1287-1296.
26. Neuhof, T.; Dieckmann, R.; von Döhren, H.; Preussel, K.; Seibold, M.; Schmieder, P. Lipopeptides Having Pharmaceutical Activity. Patent Analysis, 1698638 EP, 8 September 2006.
27. Kótai, J. Instructions for Preparation of Modified Nutrient Solution Z8 for Algae; NIVA B-11/69; Norwegian Institute for Water Research: Blindern, Oslo, Norway, 1972.
28. Allen, M.B. Simple conditions for growth of unicellular blue-green algae on plates. J. Phycol. 1968, 4, 1-4.
29. Allen, M.M.; Arnon, D.I. Studies on nitrogen-fixing blue-green algae. I. Growth and nitrogen fixation by Anabaena cylindrical Lemm. Plant Physiol. 1955, 30, 366-372.
30. Gorham, P.R.; McLachlan, J.; Hammer, U.T.; Kim, W.K. Isolation and culture of toxic strains of Anabaena flos-aquae (Lyngb.) de Bréb. Verh. Int. Verein. Theor. Angew. Limnol. 1964, 15, 796-804.
31. Jokela, J.; Oftedal, L.; Herfindal, L.; Permi, P.; Wahlsten, M.; Døskeland, S.O.; Sivonen, K. Anabaenolysins, novel cytolytic lipopeptides from benthic Anabaena cyanobacteria. PLoS ONE 2012, 7, e41222.
32. Tamura, K.; Peterson, D.; Peterson, N.; Stecher, G.; Nei, M.; Kumar, S. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28, 2731-2739.